世界のオンコロジージェネリック注射薬市場 2019年

QYResearchが発行した調査報告書(DATA908B05646)
◆英語タイトル:Global Oncology Generic Injectable Drugs Market Professional Survey Report 2019
◆商品コード:DATA908B05646
◆発行会社(リサーチ会社):QYResearch
◆発行日:2019年8月26日
◆ページ数:101
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医薬品・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,500 ⇒換算¥385,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,000 ⇒換算¥770,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

※本調査レポートは、オンコロジージェネリック注射薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、大分子薬、小分子薬に、用途別には、病院薬局、小売薬局、オンライン薬局にセグメント区分し、オンコロジージェネリック注射薬の世界市場を分析しました。


・エグゼクティブ・サマリー
・オンコロジージェネリック注射薬の世界市場概要
・オンコロジージェネリック注射薬の製造コスト構成分析
・オンコロジージェネリック注射薬の開発・製造工場分析
・主要メーカーの主な指標(生産能力、売上、価格分析)
・オンコロジージェネリック注射薬の地域別分析(生産、売上、主要メーカー、輸出・輸入)
(北米、ヨーロッパ、中国、日本国内、東南アジア、インド)
・オンコロジージェネリック注射薬のセグメント分析(種類別)
(大分子薬、小分子薬)
・オンコロジージェネリック注射薬のセグメント分析(用途別)
(病院薬局、小売薬局、オンライン薬局)
・オンコロジージェネリック注射薬の主要メーカー別分析(生産拠点、製品概要、生産・売上実績)
(Teva Pharmaceutical、Pfizer、AstraZeneca、Roche、Eli Lilly、GlaxoSmithKline、Novartis、Mylan、Natco Pharma)
・オンコロジージェネリック注射薬の市場規模予測(2019年~2025年)
(北米、ヨーロッパ、中国、日本国内、東南アジア、インド)
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス(市場動向、機会、成長要因、課題、影響因子)
...
【レポートの概要】

Generic drugs are essential in oncology because some anticancer drugs are only available as generics.
The global Oncology Generic Injectable Drugs market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Oncology Generic Injectable Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Oncology Generic Injectable Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Oncology Generic Injectable Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Oncology Generic Injectable Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Teva Pharmaceutical
Pfizer
AstraZeneca
Roche
Eli Lilly
GlaxoSmithKline
Novartis
Mylan
Natco Pharma

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Large Molecule Drugs
Small Molecule Drugs

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Oncology Generic Injectable Drugs
1.1 Definition of Oncology Generic Injectable Drugs
1.2 Oncology Generic Injectable Drugs Segment by Type
1.2.1 Global Oncology Generic Injectable Drugs Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Large Molecule Drugs
1.2.3 Small Molecule Drugs
1.3 Oncology Generic Injectable Drugs Segment by Applications
1.3.1 Global Oncology Generic Injectable Drugs Consumption Comparison by Applications (2014-2025)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Oncology Generic Injectable Drugs Overall Market
1.4.1 Global Oncology Generic Injectable Drugs Revenue (2014-2025)
1.4.2 Global Oncology Generic Injectable Drugs Production (2014-2025)
1.4.3 North America Oncology Generic Injectable Drugs Status and Prospect (2014-2025)
1.4.4 Europe Oncology Generic Injectable Drugs Status and Prospect (2014-2025)
1.4.5 China Oncology Generic Injectable Drugs Status and Prospect (2014-2025)
1.4.6 Japan Oncology Generic Injectable Drugs Status and Prospect (2014-2025)
1.4.7 Southeast Asia Oncology Generic Injectable Drugs Status and Prospect (2014-2025)
1.4.8 India Oncology Generic Injectable Drugs Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Oncology Generic Injectable Drugs
2.3 Manufacturing Process Analysis of Oncology Generic Injectable Drugs
2.4 Industry Chain Structure of Oncology Generic Injectable Drugs

3 Development and Manufacturing Plants Analysis of Oncology Generic Injectable Drugs
3.1 Capacity and Commercial Production Date
3.2 Global Oncology Generic Injectable Drugs Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Oncology Generic Injectable Drugs
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Oncology Generic Injectable Drugs Production and Capacity Analysis
4.2 Oncology Generic Injectable Drugs Revenue Analysis
4.3 Oncology Generic Injectable Drugs Price Analysis
4.4 Market Concentration Degree

5 Oncology Generic Injectable Drugs Regional Market Analysis
5.1 Oncology Generic Injectable Drugs Production by Regions
5.1.1 Global Oncology Generic Injectable Drugs Production by Regions
5.1.2 Global Oncology Generic Injectable Drugs Revenue by Regions
5.2 Oncology Generic Injectable Drugs Consumption by Regions
5.3 North America Oncology Generic Injectable Drugs Market Analysis
5.3.1 North America Oncology Generic Injectable Drugs Production
5.3.2 North America Oncology Generic Injectable Drugs Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Oncology Generic Injectable Drugs Import and Export
5.4 Europe Oncology Generic Injectable Drugs Market Analysis
5.4.1 Europe Oncology Generic Injectable Drugs Production
5.4.2 Europe Oncology Generic Injectable Drugs Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Oncology Generic Injectable Drugs Import and Export
5.5 China Oncology Generic Injectable Drugs Market Analysis
5.5.1 China Oncology Generic Injectable Drugs Production
5.5.2 China Oncology Generic Injectable Drugs Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Oncology Generic Injectable Drugs Import and Export
5.6 Japan Oncology Generic Injectable Drugs Market Analysis
5.6.1 Japan Oncology Generic Injectable Drugs Production
5.6.2 Japan Oncology Generic Injectable Drugs Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Oncology Generic Injectable Drugs Import and Export
5.7 Southeast Asia Oncology Generic Injectable Drugs Market Analysis
5.7.1 Southeast Asia Oncology Generic Injectable Drugs Production
5.7.2 Southeast Asia Oncology Generic Injectable Drugs Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Oncology Generic Injectable Drugs Import and Export
5.8 India Oncology Generic Injectable Drugs Market Analysis
5.8.1 India Oncology Generic Injectable Drugs Production
5.8.2 India Oncology Generic Injectable Drugs Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Oncology Generic Injectable Drugs Import and Export

6 Oncology Generic Injectable Drugs Segment Market Analysis (by Type)
6.1 Global Oncology Generic Injectable Drugs Production by Type
6.2 Global Oncology Generic Injectable Drugs Revenue by Type
6.3 Oncology Generic Injectable Drugs Price by Type

7 Oncology Generic Injectable Drugs Segment Market Analysis (by Application)
7.1 Global Oncology Generic Injectable Drugs Consumption by Application
7.2 Global Oncology Generic Injectable Drugs Consumption Market Share by Application (2014-2019)

8 Oncology Generic Injectable Drugs Major Manufacturers Analysis
8.1 Teva Pharmaceutical
8.1.1 Teva Pharmaceutical Oncology Generic Injectable Drugs Production Sites and Area Served
8.1.2 Teva Pharmaceutical Product Introduction, Application and Specification
8.1.3 Teva Pharmaceutical Oncology Generic Injectable Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Pfizer
8.2.1 Pfizer Oncology Generic Injectable Drugs Production Sites and Area Served
8.2.2 Pfizer Product Introduction, Application and Specification
8.2.3 Pfizer Oncology Generic Injectable Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 AstraZeneca
8.3.1 AstraZeneca Oncology Generic Injectable Drugs Production Sites and Area Served
8.3.2 AstraZeneca Product Introduction, Application and Specification
8.3.3 AstraZeneca Oncology Generic Injectable Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Roche
8.4.1 Roche Oncology Generic Injectable Drugs Production Sites and Area Served
8.4.2 Roche Product Introduction, Application and Specification
8.4.3 Roche Oncology Generic Injectable Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Eli Lilly
8.5.1 Eli Lilly Oncology Generic Injectable Drugs Production Sites and Area Served
8.5.2 Eli Lilly Product Introduction, Application and Specification
8.5.3 Eli Lilly Oncology Generic Injectable Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 GlaxoSmithKline
8.6.1 GlaxoSmithKline Oncology Generic Injectable Drugs Production Sites and Area Served
8.6.2 GlaxoSmithKline Product Introduction, Application and Specification
8.6.3 GlaxoSmithKline Oncology Generic Injectable Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Novartis
8.7.1 Novartis Oncology Generic Injectable Drugs Production Sites and Area Served
8.7.2 Novartis Product Introduction, Application and Specification
8.7.3 Novartis Oncology Generic Injectable Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Mylan
8.8.1 Mylan Oncology Generic Injectable Drugs Production Sites and Area Served
8.8.2 Mylan Product Introduction, Application and Specification
8.8.3 Mylan Oncology Generic Injectable Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Natco Pharma
8.9.1 Natco Pharma Oncology Generic Injectable Drugs Production Sites and Area Served
8.9.2 Natco Pharma Product Introduction, Application and Specification
8.9.3 Natco Pharma Oncology Generic Injectable Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served

9 Development Trend of Analysis of Oncology Generic Injectable Drugs Market
9.1 Global Oncology Generic Injectable Drugs Market Trend Analysis
9.1.1 Global Oncology Generic Injectable Drugs Market Size (Volume and Value) Forecast 2019-2025
9.2 Oncology Generic Injectable Drugs Regional Market Trend
9.2.1 North America Oncology Generic Injectable Drugs Forecast 2019-2025
9.2.2 Europe Oncology Generic Injectable Drugs Forecast 2019-2025
9.2.3 China Oncology Generic Injectable Drugs Forecast 2019-2025
9.2.4 Japan Oncology Generic Injectable Drugs Forecast 2019-2025
9.2.5 Southeast Asia Oncology Generic Injectable Drugs Forecast 2019-2025
9.2.6 India Oncology Generic Injectable Drugs Forecast 2019-2025
9.3 Oncology Generic Injectable Drugs Market Trend (Product Type)
9.4 Oncology Generic Injectable Drugs Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Oncology Generic Injectable Drugs Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Oncology Generic Injectable Drugs
Table Global Oncology Generic Injectable Drugs Production (K Units) Growth Rate Comparison by Types (2014-2025)
Figure Global Oncology Generic Injectable Drugs Production Market Share by Types in 2018
Figure Large Molecule Drugs Product Picture
Figure Small Molecule Drugs Product Picture
Table Global Oncology Generic Injectable Drugs Consumption (K Units) Comparison by Applications (2014-2025)
Figure Global Oncology Generic Injectable Drugs Consumption Market Share by Applications in 2018
Figure Hospital Pharmacies
Figure Retail Pharmacies
Figure Online Pharmacies
Figure Global Oncology Generic Injectable Drugs Revenue (Million USD) (2014-2025)
Figure Global Oncology Generic Injectable Drugs Production (K Units) (2014-2025)
Figure North America Oncology Generic Injectable Drugs Market Size (Million USD) (2014-2025)
Figure Europe Oncology Generic Injectable Drugs Market Size (Million USD) (2014-2025)
Figure China Oncology Generic Injectable Drugs Market Size (Million USD) (2014-2025)
Figure Japan Oncology Generic Injectable Drugs Market Size (Million USD) (2014-2025)
Figure Southeast Asia Oncology Generic Injectable Drugs Market Size (Million USD) (2014-2025)
Figure India Oncology Generic Injectable Drugs Market Size (Million USD) (2014-2025)
Table Oncology Generic Injectable Drugs Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Oncology Generic Injectable Drugs in 2018
Figure Manufacturing Process Analysis of Oncology Generic Injectable Drugs
Figure Industry Chain Structure of Oncology Generic Injectable Drugs
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Oncology Generic Injectable Drugs Manufacturing Plants Distribution
Table Oncology Generic Injectable Drugs Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Oncology Generic Injectable Drugs Capacity (K Units) of Major Manufacturers (2014-2019)
Table Oncology Generic Injectable Drugs Production (K Units) of Major Manufacturers (2014-2019)
Table Oncology Generic Injectable Drugs Production Market Share of Major Manufacturers (2014-2019)
Figure Oncology Generic Injectable Drugs Production Share by Manufacturers in 2018
Table Oncology Generic Injectable Drugs Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Oncology Generic Injectable Drugs Revenue Market Share of Major Manufacturers (2014-2019)
Figure Oncology Generic Injectable Drugs Revenue Share by Manufacturers in 2018
Table Oncology Generic Injectable Drugs Average Price (USD/Unit) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Oncology Generic Injectable Drugs Production by Regions 2014-2019 (K Units)
Table Global Oncology Generic Injectable Drugs Production Market Share by Regions 2014-2019
Figure Global Oncology Generic Injectable Drugs Production Market Share by Regions in 2018
Table Global Oncology Generic Injectable Drugs Revenue by Regions 2014-2019 (Million USD)
Table Global Oncology Generic Injectable Drugs Revenue Market Share by Regions 2014-2019
Figure Global Oncology Generic Injectable Drugs Revenue Market Share by Regions in 2018
Table Global Oncology Generic Injectable Drugs Consumption by Regions 2014-2019 (K Units)
Table Global Oncology Generic Injectable Drugs Consumption Market Share by Regions 2014-2019
Figure North America Oncology Generic Injectable Drugs Production Growth Rate 2014-2019 (K Units)
Figure North America Oncology Generic Injectable Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table North America Oncology Generic Injectable Drugs Production, Consumption Import and Export (K Units)
Figure Europe Oncology Generic Injectable Drugs Production Growth Rate 2014-2019 (K Units)
Figure Europe Oncology Generic Injectable Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Oncology Generic Injectable Drugs Production, Consumption Import and Export (K Units)
Figure China Oncology Generic Injectable Drugs Production Growth Rate 2014-2019 (K Units)
Figure China Oncology Generic Injectable Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table China Oncology Generic Injectable Drugs Production, Consumption Import and Export (K Units)
Figure Japan Oncology Generic Injectable Drugs Production Growth Rate 2014-2019 (K Units)
Figure Japan Oncology Generic Injectable Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Oncology Generic Injectable Drugs Production, Consumption Import and Export (K Units)
Figure Southeast Asia Oncology Generic Injectable Drugs Production Growth Rate 2014-2019 (K Units)
Figure Southeast Asia Oncology Generic Injectable Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Oncology Generic Injectable Drugs Production, Consumption Import and Export (K Units)
Figure India Oncology Generic Injectable Drugs Production Growth Rate 2014-2019 (K Units)
Figure India Oncology Generic Injectable Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table India Oncology Generic Injectable Drugs Production, Consumption Import and Export (K Units)
Figure Global Consumption Oncology Generic Injectable Drugs Market Share by Application (2014-2019)
Figure Global Value (Consumption) Oncology Generic Injectable Drugs Market Share by Application (2014-2019)
Table Teva Pharmaceutical Oncology Generic Injectable Drugs Production Sites and Area Served
Table Teva Pharmaceutical Oncology Generic Injectable Drugs Product Introduction, Application and Specification
Table Teva Pharmaceutical Oncology Generic Injectable Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Teva Pharmaceutical Oncology Generic Injectable Drugs Production Growth Rate (2014-2019)
Table Teva Pharmaceutical Oncology Generic Injectable Drugs Production Market Share (2014-2019)
Figure Teva Pharmaceutical Oncology Generic Injectable Drugs Revenue Market Share (2014-2019)
Table Teva Pharmaceutical Oncology Generic Injectable Drugs Main Business and Markets Served
Table Pfizer Oncology Generic Injectable Drugs Production Sites and Area Served
Table Pfizer Oncology Generic Injectable Drugs Product Introduction, Application and Specification
Table Pfizer Oncology Generic Injectable Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Oncology Generic Injectable Drugs Production Growth Rate (2014-2019)
Table Pfizer Oncology Generic Injectable Drugs Production Market Share (2014-2019)
Figure Pfizer Oncology Generic Injectable Drugs Revenue Market Share (2014-2019)
Table Pfizer Oncology Generic Injectable Drugs Main Business and Markets Served
Table AstraZeneca Oncology Generic Injectable Drugs Production Sites and Area Served
Table AstraZeneca Oncology Generic Injectable Drugs Product Introduction, Application and Specification
Table AstraZeneca Oncology Generic Injectable Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table AstraZeneca Oncology Generic Injectable Drugs Production Growth Rate (2014-2019)
Table AstraZeneca Oncology Generic Injectable Drugs Production Market Share (2014-2019)
Figure AstraZeneca Oncology Generic Injectable Drugs Revenue Market Share (2014-2019)
Table AstraZeneca Oncology Generic Injectable Drugs Main Business and Markets Served
Table Roche Oncology Generic Injectable Drugs Production Sites and Area Served
Table Roche Oncology Generic Injectable Drugs Product Introduction, Application and Specification
Table Roche Oncology Generic Injectable Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Roche Oncology Generic Injectable Drugs Production Growth Rate (2014-2019)
Table Roche Oncology Generic Injectable Drugs Production Market Share (2014-2019)
Figure Roche Oncology Generic Injectable Drugs Revenue Market Share (2014-2019)
Table Roche Oncology Generic Injectable Drugs Main Business and Markets Served
Table Eli Lilly Oncology Generic Injectable Drugs Production Sites and Area Served
Table Eli Lilly Oncology Generic Injectable Drugs Product Introduction, Application and Specification
Table Eli Lilly Oncology Generic Injectable Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Eli Lilly Oncology Generic Injectable Drugs Production Growth Rate (2014-2019)
Table Eli Lilly Oncology Generic Injectable Drugs Production Market Share (2014-2019)
Figure Eli Lilly Oncology Generic Injectable Drugs Revenue Market Share (2014-2019)
Table Eli Lilly Oncology Generic Injectable Drugs Main Business and Markets Served
Table GlaxoSmithKline Oncology Generic Injectable Drugs Production Sites and Area Served
Table GlaxoSmithKline Oncology Generic Injectable Drugs Product Introduction, Application and Specification
Table GlaxoSmithKline Oncology Generic Injectable Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table GlaxoSmithKline Oncology Generic Injectable Drugs Production Growth Rate (2014-2019)
Table GlaxoSmithKline Oncology Generic Injectable Drugs Production Market Share (2014-2019)
Figure GlaxoSmithKline Oncology Generic Injectable Drugs Revenue Market Share (2014-2019)
Table GlaxoSmithKline Oncology Generic Injectable Drugs Main Business and Markets Served
Table Novartis Oncology Generic Injectable Drugs Production Sites and Area Served
Table Novartis Oncology Generic Injectable Drugs Product Introduction, Application and Specification
Table Novartis Oncology Generic Injectable Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis Oncology Generic Injectable Drugs Production Growth Rate (2014-2019)
Table Novartis Oncology Generic Injectable Drugs Production Market Share (2014-2019)
Figure Novartis Oncology Generic Injectable Drugs Revenue Market Share (2014-2019)
Table Novartis Oncology Generic Injectable Drugs Main Business and Markets Served
Table Mylan Oncology Generic Injectable Drugs Production Sites and Area Served
Table Mylan Oncology Generic Injectable Drugs Product Introduction, Application and Specification
Table Mylan Oncology Generic Injectable Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Mylan Oncology Generic Injectable Drugs Production Growth Rate (2014-2019)
Table Mylan Oncology Generic Injectable Drugs Production Market Share (2014-2019)
Figure Mylan Oncology Generic Injectable Drugs Revenue Market Share (2014-2019)
Table Mylan Oncology Generic Injectable Drugs Main Business and Markets Served
Table Natco Pharma Oncology Generic Injectable Drugs Production Sites and Area Served
Table Natco Pharma Oncology Generic Injectable Drugs Product Introduction, Application and Specification
Table Natco Pharma Oncology Generic Injectable Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Natco Pharma Oncology Generic Injectable Drugs Production Growth Rate (2014-2019)
Table Natco Pharma Oncology Generic Injectable Drugs Production Market Share (2014-2019)
Figure Natco Pharma Oncology Generic Injectable Drugs Revenue Market Share (2014-2019)
Table Natco Pharma Oncology Generic Injectable Drugs Main Business and Markets Served
Figure Global Oncology Generic Injectable Drugs Production (K Units) Growth Rate Forecast 2019-2025
Figure Global Oncology Generic Injectable Drugs Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Oncology Generic Injectable Drugs Sales Price (USD/Unit) Forecast 2019-2025
Figure North America Oncology Generic Injectable Drugs Production Growth Rate Forecast 2019-2025 (K Units)
Figure North America Oncology Generic Injectable Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Oncology Generic Injectable Drugs Production Growth Rate Forecast 2019-2025 (K Units)
Figure Europe Oncology Generic Injectable Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Oncology Generic Injectable Drugs Production Growth Rate Forecast 2019-2025 (K Units)
Figure China Oncology Generic Injectable Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Oncology Generic Injectable Drugs Production Growth Rate Forecast 2019-2025 (K Units)
Figure Japan Oncology Generic Injectable Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Oncology Generic Injectable Drugs Production Growth Rate Forecast 2019-2025 (K Units)
Figure Southeast Asia Oncology Generic Injectable Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Oncology Generic Injectable Drugs Production Growth Rate Forecast 2019-2025 (K Units)
Figure India Oncology Generic Injectable Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Units) of Oncology Generic Injectable Drugs by Type (2019-2025)
Table Global Consumption (K Units) of Oncology Generic Injectable Drugs by Application (2019-2025)
Table Oncology Generic Injectable Drugs Distributors List
Table Oncology Generic Injectable Drugs Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Teva Pharmaceutical、Pfizer、AstraZeneca、Roche、Eli Lilly、GlaxoSmithKline、Novartis、Mylan、Natco Pharma

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のオンコロジージェネリック注射薬市場 2019年(Global Oncology Generic Injectable Drugs Market Professional Survey Report 2019)]についてメールでお問い合わせはこちらでお願いします。